Overexpression of vascular permeability factor/vascular endothelial growth factor and its receptors in psoriasis

doi:10.1084/jem.180.3.1141

This Article

	Full Text (PDF, 2403K)
	Alert me when this article is cited
	Citation Map

Services

	Email this article
	Similar articles in this journal
	Similar articles in PubMed
	Alert me to new content in the JEM
	Download to citation manager

Citing Articles

	Citing Articles via HighWire
	Citing Articles via CrossRef
	Citing Articles via Google Scholar

Google Scholar

	Articles by Detmar, M.
	Articles by Dvorak, H. F.
	Search for Related Content

PubMed

	PubMed Citation
	Articles by Detmar, M.
	Articles by Dvorak, H. F.


Social Bookmarking

	What's this?

ARTICLES

Overexpression of vascular permeability factor/vascular endothelial growth factor and its receptors in psoriasis

M Detmar, LF Brown, KP Claffey, KT Yeo, O Kocher, RW Jackman, B Berse and HF Dvorak
Department of Pathology, Beth Israel Hospital, Harvard Medical School, Boston, Massachusetts 02215.

Psoriatic skin is characterized by microvascular hyperpermeability and angioproliferation, but the mechanisms responsible are unknown. We report here that the hyperplastic epidermis of psoriatic skin expresses strikingly increased amounts of vascular permeability factor (VPF; vascular endothelial growth factor), a selective endothelial cell mitogen that enhances microvascular permeability. Moreover, two VPF receptors, kdr and flt-1, are overexpressed by papillary dermal microvascular endothelial cells. Transforming growth factor alpha (TGF- alpha), a cytokine that is also overexpressed in psoriatic epidermis, induced VPF gene expression by cultured epidermal keratinocytes. VPF secreted by TGF-alpha-stimulated keratinocytes was bioactive, as demonstrated by its mitogenic effect on dermal microvascular endothelial cells in vitro. Together, these findings suggest that TGF- alpha regulates VPF expression in psoriasis by an autocrine mechanism, leading to vascular hyperpermeability and angiogenesis. Similar mechanisms may operate in tumors and in healing skin wounds which also commonly express both VPF and TGF-alpha.
Add to CiteULike CiteULike Add to Complore Complore Add to Connotea Connotea Add to Del.icio.us Del.icio.us Add to Digg Digg Add to Reddit Reddit Add to Technorati Technorati What's this?

This article has been cited by other articles:

Anderson, C. R., Hastings, N. E., Blackman, B. R., Price, R. J. (2008). Capillary Sprout Endothelial Cells Exhibit a CD36low Phenotype: Regulation by Shear Stress and Vascular Endothelial Growth Factor-Induced Mechanism for Attenuating Anti-Proliferative Thrombospondin-1 Signaling. Am. J. Pathol. 173: 1220-1228 [Abstract] [Full Text]
Hvid, H., Teige, I., Kvist, P. H., Svensson, L., Kemp, K. (2008). TPA induction leads to a Th17-like response in transgenic K14/VEGF mice: a novel in vivo screening model of psoriasis. Int Immunol 20: 1097-1106 [Abstract] [Full Text]
Sasaki, T., Nakamura, T., Rebhun, R. B., Cheng, H., Hale, K. S., Tsan, R. Z., Fidler, I. J., Langley, R. R. (2008). Modification of the Primary Tumor Microenvironment by Transforming Growth Factor {alpha}-Epidermal Growth Factor Receptor Signaling Promotes Metastasis in an Orthotopic Colon Cancer Model. Am. J. Pathol. 173: 205-216 [Abstract] [Full Text]
Halin, C., Fahrngruber, H., Meingassner, J. G., Bold, G., Littlewood-Evans, A., Stuetz, A., Detmar, M. (2008). Inhibition of Chronic and Acute Skin Inflammation by Treatment with a Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitor. Am. J. Pathol. 173: 265-277 [Abstract] [Full Text]
Halin, C., Tobler, N. E., Vigl, B., Brown, L. F., Detmar, M. (2007). VEGF-A produced by chronically inflamed tissue induces lymphangiogenesis in draining lymph nodes. Blood 110: 3158-3167 [Abstract] [Full Text]
Eichten, A., Hyun, W. C., Coussens, L. M. (2007). Distinctive Features of Angiogenesis and Lymphangiogenesis Determine Their Functionality during De novo Tumor Development. Cancer Res. 67: 5211-5220 [Abstract] [Full Text]
Ray, B. K., Shakya, A., Ray, A. (2007). Vascular Endothelial Growth Factor Expression in Arthritic Joint Is Regulated by SAF-1 Transcription Factor. J. Immunol. 178: 1774-1782 [Abstract] [Full Text]
Smith, J. R, Lanier, V. B, Braziel, R. M, Falkenhagen, K. M, White, C., Rosenbaum, J. T (2007). Expression of vascular endothelial growth factor and its receptors in rosacea. Br. J. Ophthalmol. 91: 226-229 [Abstract] [Full Text]
van Kuijk, A W R, Reinders-Blankert, P, Smeets, T J M, Dijkmans, B A C, Tak, P P (2006). Detailed analysis of the cell infiltrate and the expression of mediators of synovial inflammation and joint destruction in the synovium of patients with psoriatic arthritis: implications for treatment. Ann Rheum Dis 65: 1551-1557 [Abstract] [Full Text]
Cao, J., Cetrulo, C. L., Theoharides, T. C. (2006). Corticotropin-Releasing Hormone Induces Vascular Endothelial Growth Factor Release from Human Mast Cells via the cAMP/Protein Kinase A/p38 Mitogen-Activated Protein Kinase Pathway. Mol. Pharmacol. 69: 998-1006 [Abstract] [Full Text]
Wang, Y., Iyer, M., Annala, A., Wu, L., Carey, M., Gambhir, S. S. (2006). Noninvasive indirect imaging of vascular endothelial growth factor gene expression using bioluminescence imaging in living transgenic mice. Physiol. Genomics 24: 173-180 [Abstract] [Full Text]
Wilgus, T. A., Matthies, A. M., Radek, K. A., Dovi, J. V., Burns, A. L., Shankar, R., DiPietro, L. A. (2005). Novel Function for Vascular Endothelial Growth Factor Receptor-1 on Epidermal Keratinocytes. Am. J. Pathol. 167: 1257-1266 [Abstract] [Full Text]
Sonkoly, E., Bata-Csorgo, Z., Pivarcsi, A., Polyanka, H., Kenderessy-Szabo, A., Molnar, G., Szentpali, K., Bari, L., Megyeri, K., Mandi, Y., Dobozy, A., Kemeny, L., Szell{section}, M. (2005). Identification and Characterization of a Novel, Psoriasis Susceptibility-related Noncoding RNA gene, PRINS. J. Biol. Chem. 280: 24159-24167 [Abstract] [Full Text]
Schön, M. P., Boehncke, W.-H. (2005). Psoriasis. NEJM 352: 1899-1912 [Full Text]
Kaur, B., Khwaja, F. W., Severson, E. A., Matheny, S. L., Brat, D. J., Van Meir, E. G. (2005). Hypoxia and the hypoxia-inducible-factor pathway in glioma growth and angiogenesis. Neuro Oncol 7: 134-153 [Abstract]
Bae, D.-G., Kim, T.-D., Li, G., Yoon, W.-H., Chae, C.-B. (2005). Anti-Flt1 Peptide, a Vascular Endothelial Growth Factor Receptor 1-Specific Hexapeptide, Inhibits Tumor Growth and Metastasis. Clin. Cancer Res. 11: 2651-2661 [Abstract] [Full Text]
Hirakawa, S., Fujii, S., Kajiya, K., Yano, K., Detmar, M. (2005). Vascular endothelial growth factor promotes sensitivity to ultraviolet B-induced cutaneous photodamage. Blood 105: 2392-2399 [Abstract] [Full Text]
Pages, G., Pouyssegur, J. (2005). Transcriptional regulation of the Vascular Endothelial Growth Factor gene-a concert of activating factors. Cardiovasc Res 65: 564-573 [Abstract] [Full Text]
Hoeben, A., Landuyt, B., Highley, M. S., Wildiers, H., Van Oosterom, A. T., De Bruijn, E. A. (2004). Vascular Endothelial Growth Factor and Angiogenesis. Pharmacol. Rev. 56: 549-580 [Abstract] [Full Text]
Knies-Bamforth, U. E., Fox, S. B., Poulsom, R., Evan, G. I., Harris, A. L. (2004). c-Myc Interacts with Hypoxia to Induce Angiogenesis In vivo by a Vascular Endothelial Growth Factor-Dependent Mechanism. Cancer Res. 64: 6563-6570 [Abstract] [Full Text]
Kunstfeld, R., Hirakawa, S., Hong, Y.-K., Schacht, V., Lange-Asschenfeldt, B., Velasco, P., Lin, C., Fiebiger, E., Wei, X., Wu, Y., Hicklin, D., Bohlen, P., Detmar, M. (2004). Induction of cutaneous delayed-type hypersensitivity reactions in VEGF-A transgenic mice results in chronic skin inflammation associated with persistent lymphatic hyperplasia. Blood 104: 1048-1057 [Abstract] [Full Text]
Miura, S., Tatsuguchi, A., Wada, K., Takeyama, H., Shinji, Y., Hiratsuka, T., Futagami, S., Miyake, K., Gudis, K., Mizokami, Y., Matsuoka, T., Sakamoto, C. (2004). Cyclooxygenase-2-regulated vascular endothelial growth factor release in gastric fibroblasts. Am. J. Physiol. Gastrointest. Liver Physiol. 287: G444-G451 [Abstract] [Full Text]
Shie, J.-L., Wu, G., Wu, J., Liu, F.-F., Laham, R. J., Oettgen, P., Li, J. (2004). RTEF-1, a Novel Transcriptional Stimulator of Vascular Endothelial Growth Factor in Hypoxic Endothelial Cells. J. Biol. Chem. 279: 25010-25016 [Abstract] [Full Text]
Rossiter, H., Barresi, C., Pammer, J., Rendl, M., Haigh, J., Wagner, E. F., Tschachler, E. (2004). Loss of Vascular Endothelial Growth Factor A Activity in Murine Epidermal Keratinocytes Delays Wound Healing and Inhibits Tumor Formation. Cancer Res. 64: 3508-3516 [Abstract] [Full Text]
Meissner, M., Stein, M., Urbich, C., Reisinger, K., Suske, G., Staels, B., Kaufmann, R., Gille, J. (2004). PPAR{alpha} Activators Inhibit Vascular Endothelial Growth Factor Receptor-2 Expression by Repressing Sp1-Dependent DNA Binding and Transactivation. Circ. Res. 94: 324-332 [Abstract] [Full Text]
Xia, Y.-P., Li, B., Hylton, D., Detmar, M., Yancopoulos, G. D., Rudge, J. S. (2003). Transgenic delivery of VEGF to mouse skin leads to an inflammatory condition resembling human psoriasis. Blood 102: 161-168 [Abstract] [Full Text]
Dadras, S. S., Paul, T., Bertoncini, J., Brown, L. F., Muzikansky, A., Jackson, D. G., Ellwanger, U., Garbe, C., Mihm, M. C., Detmar, M. (2003). Tumor Lymphangiogenesis: A Novel Prognostic Indicator for Cutaneous Melanoma Metastasis and Survival. Am. J. Pathol. 162: 1951-1960 [Abstract] [Full Text]
Reisinger, K., Kaufmann, R., Gille, J. (2003). Increased Sp1 phosphorylation as a mechanism of hepatocyte growth factor (HGF/SF)-induced vascular endothelial growth factor (VEGF/VPF) transcription. J. Cell Sci. 116: 225-238 [Abstract] [Full Text]
Oura, H., Bertoncini, J., Velasco, P., Brown, L. F., Carmeliet, P., Detmar, M. (2003). A critical role of placental growth factor in the induction of inflammation and edema formation. Blood 101: 560-567 [Abstract] [Full Text]
Holash, J., Davis, S., Papadopoulos, N., Croll, S. D., Ho, L., Russell, M., Boland, P., Leidich, R., Hylton, D., Burova, E., Ioffe, E., Huang, T., Radziejewski, C., Bailey, K., Fandl, J. P., Daly, T., Wiegand, S. J., Yancopoulos, G. D., Rudge, J. S. (2002). VEGF-Trap: A VEGF blocker with potent antitumor effects. Proc. Natl. Acad. Sci. USA 99: 11393-11398 [Abstract] [Full Text]
Stoll, S. W., Kansra, S., Elder, J. T. (2002). Metalloproteinases Stimulate ErbB-dependent ERK Signaling in Human Skin Organ Culture. J. Biol. Chem. 277: 26839-26845 [Abstract] [Full Text]
Creamer, D., Allen, M., Jaggar, R., Stevens, R., Bicknell, R., Barker, J. (2002). Mediation of Systemic Vascular Hyperpermeability in Severe Psoriasis by Circulating Vascular Endothelial Growth Factor. Arch Dermatol 138: 791-796 [Abstract] [Full Text]
Hawighorst, T., Skobe, M., Streit, M., Hong, Y.-K., Velasco, P., Brown, L. F., Riccardi, L., Lange-Asschenfeldt, B., Detmar, M. (2002). Activation of the Tie2 Receptor by Angiopoietin-1 Enhances Tumor Vessel Maturation and Impairs Squamous Cell Carcinoma Growth. Am. J. Pathol. 160: 1381-1392 [Abstract] [Full Text]
Lange-Asschenfeldt, B., Weninger, W., Velasco, P., Kyriakides, T. R., von Andrian, U. H., Bornstein, P., Detmar, M. (2002). Increased and prolonged inflammation and angiogenesis in delayed-type hypersensitivity reactions elicited in the skin of thrombospondin-2-deficient mice. Blood 99: 538-545 [Abstract] [Full Text]
McInnes, I. B., Illei, G. G., Danning, C. L., Yarboro, C. H., Crane, M., Kuroiwa, T., Schlimgen, R., Lee, E., Foster, B., Flemming, D., Prussin, C., Fleisher, T. A., Boumpas, D. T. (2001). IL-10 Improves Skin Disease and Modulates Endothelial Activation and Leukocyte Effector Function in Patients with Psoriatic Arthritis. J. Immunol. 167: 4075-4082 [Abstract] [Full Text]
Graubert, M. D., Asuncion Ortega, M., Kessel, B., Mortola, J. F., Iruela-Arispe, M. L. (2001). Vascular Repair After Menstruation Involves Regulation of Vascular Endothelial Growth Factor-Receptor Phosphorylation by sFLT-1. Am. J. Pathol. 158: 1399-1410 [Abstract] [Full Text]
Hernandez, G. L., Volpert, O. V., Iniguez, M. A., Lorenzo, E., Martinez-Martinez, S., Grau, R., Fresno, M., Redondo, J. M. (2001). Selective Inhibition of Vascular Endothelial Growth Factor-mediated Angiogenesis by Cyclosporin A: Roles of the Nuclear Factor of Activated T Cells and Cyclooxygenase 2. JEM 193: 607-620 [Abstract] [Full Text]
Philipp, W., Speicher, L., Humpel, C. (2000). Expression of Vascular Endothelial Growth Factor and Its Receptors in Inflamed and Vascularized Human Corneas. IOVS 41: 2514-2522 [Abstract] [Full Text]
Kishimoto, J., Ehama, R., Ge, Y., Kobayashi, T., Nishiyama, T., Detmar, M., Burgeson, R. E. (2000). In Vivo Detection of Human Vascular Endothelial Growth Factor Promoter Activity in Transgenic Mouse Skin. Am. J. Pathol. 157: 103-110 [Abstract] [Full Text]
Homey, B., Dieu-Nosjean, M.-C., Wiesenborn, A., Massacrier, C., Pin, J.-J., Oldham, E., Catron, D., Buchanan, M. E., Muller, A., deWaal Malefyt, R., Deng, G., Orozco, R., Ruzicka, T., Lehmann, P., Lebecque, S., Caux, C., Zlotnik, A. (2000). Up-Regulation of Macrophage Inflammatory Protein-3{alpha}/CCL20 and CC Chemokine Receptor 6 in Psoriasis. J. Immunol. 164: 6621-6632 [Abstract] [Full Text]
Griffioen, A. W., Molema, G. (2000). Angiogenesis: Potentials for Pharmacologic Intervention in the Treatment of Cancer, Cardiovascular Diseases, and Chronic Inflammation. Pharmacol. Rev. 52: 237-268 [Abstract] [Full Text]
Feng, D., Nagy, J. A., Brekken, R. A., Pettersson, A., Manseau, E. J., Pyne, K., Mulligan, R., Thorpe, P. E., Dvorak, H. F., Dvorak, A. M. (2000). Ultrastructural Localization of the Vascular Permeability Factor/Vascular Endothelial Growth Factor (VPF/VEGF) Receptor-2 (FLK-1, KDR) in Normal Mouse Kidney and in the Hyperpermeable Vessels Induced by VPF/VEGF-expressing Tumors and Adenoviral Vectors. J. Histochem. Cytochem. 48: 545-556 [Abstract] [Full Text]
Wood, J. M., Bold, G., Buchdunger, E., Cozens, R., Ferrari, S., Frei, J., Hofmann, F., Mestan, J., Mett, H., O’Reilly, T., Persohn, E., Rösel, J., Schnell, C., Stover, D., Theuer, A., Towbin, H., Wenger, F., Woods-Cook, K., Menrad, A., Siemeister, G., Schirner, M., Thierauch, K.-H., Schneider, M. R., Drevs, J., Martiny-Baron, G., Totzke, F., Marmé, D. (2000). PTK787/ZK 222584, a Novel and Potent Inhibitor of Vascular Endothelial Growth Factor Receptor Tyrosine Kinases, Impairs Vascular Endothelial Growth Factor-induced Responses and Tumor Growth after Oral Administration. Cancer Res. 60: 2178-2189 [Abstract] [Full Text]
Shirakata, Y., Komurasaki, T., Toyoda, H., Hanakawa, Y., Yamasaki, K., Tokumaru, S., Sayama, K., Hashimoto, K. (2000). Epiregulin, a Novel Member of the Epidermal Growth Factor Family, Is an Autocrine Growth Factor in Normal Human Keratinocytes. J. Biol. Chem. 275: 5748-5753 [Abstract] [Full Text]
Diaz, B. V., Lenoir, M.-C., Ladoux, A., Frelin, C., Demarchez, M., Michel, S. (2000). Regulation of Vascular Endothelial Growth Factor Expression in Human Keratinocytes by Retinoids. J. Biol. Chem. 275: 642-650 [Abstract] [Full Text]
Detmar, M., Velasco, P., Richard, L., Claffey, K. P., Streit, M., Riccardi, L., Skobe, M., Brown, L. F. (2000). Expression of Vascular Endothelial Growth Factor Induces an Invasive Phenotype in Human Squamous Cell Carcinomas. Am. J. Pathol. 156: 159-167 [Abstract] [Full Text]
Streit, M., Riccardi, L., Velasco, P., Brown, L. F., Hawighorst, T., Bornstein, P., Detmar, M. (1999). Thrombospondin-2: A potent endogenous inhibitor of tumor growth and angiogenesis. Proc. Natl. Acad. Sci. USA 96: 14888-14893 [Abstract] [Full Text]
Wang, D., Huang, H-J. S., Kazlauskas, A., Cavenee, W. K. (1999). Induction of Vascular Endothelial Growth Factor Expression in Endothelial Cells by Platelet-derived Growth Factor through the Activation of Phosphatidylinositol 3-Kinase. Cancer Res. 59: 1464-1472 [Abstract] [Full Text]
Smith, G., McLeod, D., Foreman, D., Boulton, M. (1999). Immunolocalisation of the VEGF receptors FLT-1, KDR, and FLT-4 in diabetic retinopathy. Br. J. Ophthalmol. 83: 486-494 [Abstract] [Full Text]
Lynch, C. N., Wang, Y. C., Lund, J. K., Chen, Y.-W., Leal, J. A., Wiley, S. R. (1999). TWEAK Induces Angiogenesis and Proliferation of Endothelial Cells. J. Biol. Chem. 274: 8455-8459 [Abstract] [Full Text]
Ryan, A. M., Eppler, D. B., Hagler, K. E., Bruner, R. H., Thomford, P. J., Hall, R. L., Shopp, G. M., O'Neill, C. A. (1999). Preclinical Safety Evaluation of rhuMAbVEGF, an Antiangiogenic Humanized Monoclonal Antibody. Toxicol Pathol 27: 78-86 [Abstract]
Pal, S., Claffey, K. P., Cohen, H. T., Mukhopadhyay, D. (1998). Activation of Sp1-mediated Vascular Permeability Factor/Vascular Endothelial Growth Factor Transcription Requires Specific Interaction with Protein Kinase C zeta. J. Biol. Chem. 273: 26277-26280 [Abstract] [Full Text]
Mesiano, S., Ferrara, N., Jaffe, R. B. (1998). Role of Vascular Endothelial Growth Factor in Ovarian Cancer : Inhibition of Ascites Formation by Immunoneutralization. Am. J. Pathol. 153: 1249-1256 [Abstract] [Full Text]
Ruckman, J., Green, L. S., Beeson, J., Waugh, S., Gillette, W. L., Henninger, D. D., Claesson-Welsh, L., Janjic, N. (1998). 2'-Fluoropyrimidine RNA-based Aptamers to the 165-Amino Acid Form of Vascular Endothelial Growth Factor (VEGF165). INHIBITION OF RECEPTOR BINDING AND VEGF-INDUCED VASCULAR PERMEABILITY THROUGH INTERACTIONS REQUIRING THE EXON 7-ENCODED DOMAIN. J. Biol. Chem. 273: 20556-20567 [Abstract] [Full Text]
Siemeister, G., Marme, D., Martiny-Baron, G. (1998). The alpha -Helical Domain Near the Amino Terminus Is Essential for Dimerization of Vascular Endothelial Growth Factor. J. Biol. Chem. 273: 11115-11120 [Abstract] [Full Text]
Siemeister, G., Schirner, M., Reusch, P., Barleon, B., Marme, D., Martiny-Baron, G. (1998). An antagonistic vascular endothelial growth factor (VEGF) variant inhibits VEGF-stimulated receptor autophosphorylation and proliferation of human endothelial cells. Proc. Natl. Acad. Sci. USA 95: 4625-4629 [Abstract] [Full Text]
Senger, D. R., Claffey, K. P., Benes, J. E., Perruzzi, C. A., Sergiou, A. P., Detmar, M. (1997). Angiogenesis promoted by vascular endothelial growth factor: Regulation through alpha 1beta 1 and alpha 2beta 1�integrins. Proc. Natl. Acad. Sci. USA 94: 13612-13617 [Abstract] [Full Text]
Gaudry, M., Bregerie, O., Andrieu, V., El Benna, J., Pocidalo, M.-A., Hakim, J. (1997). Intracellular Pool of Vascular Endothelial Growth Factor in Human Neutrophils. Blood 90: 4153-4161 [Abstract] [Full Text]
Pal, S., Claffey, K. P., Dvorak, H. F., Mukhopadhyay, D. (1997). The von Hippel-Lindau Gene Product Inhibits Vascular Permeability Factor/Vascular Endothelial Growth Factor Expression in Renal Cell Carcinoma by Blocking Protein Kinase C Pathways. J. Biol. Chem. 272: 27509-27512 [Abstract] [Full Text]
SCHLINGEMANN, R. O, VAN HINSBERGH, V. W M (1997). Role of vascular permeability factor/vascular endothelial growth factor in eye disease. Br. J. Ophthalmol. 81: 501-512 [Full Text]
van der Zee, R., Murohara, T., Luo, Z., Zollmann, F., Passeri, J., Lekutat, C., Isner, J. M. (1997). Vascular Endothelial Growth Factor/Vascular Permeability Factor Augments Nitric Oxide Release From Quiescent Rabbit and Human Vascular Endothelium. Circulation 95: 1030-1037 [Abstract] [Full Text]
Ferrara, N., Davis-Smyth, T. (1997). The Biology of Vascular Endothelial Growth Factor. Endocr. Rev. 18: 4-25 [Abstract] [Full Text]
Warren, R. S., Yuan, H., Matli, M. R., Ferrara, N., Donner, D. B. (1996). Induction of Vascular Endothelial Growth Factor by Insulin-like Growth Factor 1in Colorectal Carcinoma. J. Biol. Chem. 271: 29483-29488 [Abstract] [Full Text]
Brauchle, M., Funk, J., Kind, P., Werner, S. (1996). Ultraviolet B and H2O2 Are Potent Inducers of Vascular Endothelial Growth Factor Expression in Cultured Keratinocytes. J. Biol. Chem. 271: 21793-21797 [Abstract] [Full Text]
Thomas, K. A., Thomas, K. A. (1996). Vascular Endothelial Growth Factor, a Potent and Selective Angiogenic Agent. J. Biol. Chem. 271: 603-606 [Full Text]
Roberts, W., Palade, G. (1995). Increased microvascular permeability and endothelial fenestration induced by vascular endothelial growth factor. J. Cell Sci. 108: 2369-2379 [Abstract]
Wang, D., Donner, D. B., Warren, R. S. (2000). Homeostatic Modulation of Cell Surface KDR and Flt1 Expression and Expression of the Vascular Endothelial Cell Growth Factor (VEGF) Receptor mRNAs by VEGF. J. Biol. Chem. 275: 15905-15911 [Abstract] [Full Text]